Krt13em1(cre/ERT2)Cya
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Krt13em1(cre/ERT2)Cya |
| Name: |
keratin 13; endonuclease-mediated mutation 1, Cyagen Biosciences |
| MGI ID: |
MGI:8235635 |
| Synonyms: |
Krt13em1(P2A-CreERT2) |
| Gene: |
Krt13 Location: Chr11:100008153-100012392 bp, - strand Genetic Position: Chr11, 63.41 cM
|
| Alliance: |
Krt13em1(cre/ERT2)Cya page
|
|
|
|
| Allele Type: |
|
Endonuclease-mediated (Inducible, Recombinase) |
| Inducer: |
|
tamoxifen |
| Mutation: |
|
Insertion
|
| |
|
Krt13em1(cre/ERT2)Cya expression driven by
1 gene
Knock-in expression driven by:
| Organism |
Driver Gene |
Note |
| mouse |
Krt13 (MGI:101925) |
|
|
| |
|
Mutation details: Krt13-CreERT2 allele are generated via genome editing by replacing the TAA stop codon of the mouse gene with a P2A-CreERT2 cassette. Without tamoxifen treatment, CreERT2 recombinase primarily resides in the cytoplasm; nuclear translocation and recombination activity of CreERT2 only occur upon tamoxifen stimulation. When crossed with allele containing loxP sites, offspring are expected to undergo Cre-mediated recombination between loxP sites specifically in Krt13-positive cells following tamoxifen administration.
(J:326541)
|
|
|
|
Activity: |
 Tissue activity of this recombinase allele
|
|
Driver:
|
Krt13
(mouse)
|
| |
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Krt13 Mutation: |
36 strains or lines available
|
|
|
|
Analysis Tools
